BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang CY, Duan JX, Yang HH, Sun CC, Zhong WJ, Tao JH, Guan XX, Jiang HL, Hammock BD, Hwang SH, Zhou Y, Guan CX. COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence. FEBS J 2020;287:1666-80. [PMID: 31646730 DOI: 10.1111/febs.15105] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hudkova O, Krysiuk IP, Kishko TO, Popova NM, Drobot LB, Latyshko NV; Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;, Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;. Semicarbazide diminishes the signs of bleomycin-induced pulmonary fibrosis in rats. Ukr Biochem J 2021;93:72-81. [DOI: 10.15407/ubj93.05.072] [Reference Citation Analysis]
2 Zhong WJ, Duan JX, Liu T, Yang HH, Guan XX, Zhang CY, Yang JT, Xiong JB, Zhou Y, Guan CX, Li Q. Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18. Int Immunopharmacol 2020;89:107045. [PMID: 33045564 DOI: 10.1016/j.intimp.2020.107045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yang HH, Duan JX, Liu SK, Xiong JB, Guan XX, Zhong WJ, Sun CC, Zhang CY, Luo XQ, Zhang YF, Chen P, Hammock BD, Hwang SH, Jiang JX, Zhou Y, Guan CX. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. Theranostics 2020;10:4749-61. [PMID: 32308747 DOI: 10.7150/thno.43108] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
4 Khan MAH, Hwang SH, Barnett SD, Stavniichuk A, Jankiewicz WK, Hammock BD, Imig JD. Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats. Br J Pharmacol 2021. [PMID: 34255857 DOI: 10.1111/bph.15623] [Reference Citation Analysis]
5 Fishbein A, Wang W, Yang H, Yang J, Hallisey VM, Deng J, Verheul SML, Hwang SH, Gartung A, Wang Y, Bielenberg DR, Huang S, Kieran MW, Hammock BD, Panigrahy D. Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression. Proc Natl Acad Sci U S A 2020;117:21576-87. [PMID: 32801214 DOI: 10.1073/pnas.2007412117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
6 Hiesinger K, Kramer JS, Beyer S, Eckes T, Brunst S, Flauaus C, Wittmann SK, Weizel L, Kaiser A, Kretschmer SBM, George S, Angioni C, Heering J, Geisslinger G, Schubert-zsilavecz M, Schmidtko A, Pogoryelov D, Pfeilschifter J, Hofmann B, Steinhilber D, Schwalm S, Proschak E. Design, Synthesis, and Structure–Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase. J Med Chem 2020;63:11498-521. [DOI: 10.1021/acs.jmedchem.0c00561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Zhang C, Guan X, Song Z, Jiang H, Liu Y, Chen P, Duan J, Zhou Y, Poggi A. COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells via Nrf2-Mediated Inhibition of TGF-β1/Smad Signaling. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/5759626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Luo XQ, Duan JX, Yang HH, Zhang CY, Sun CC, Guan XX, Xiong JB, Zu C, Tao JH, Zhou Y, Guan CX. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages. J Cell Physiol 2020;235:9910-21. [PMID: 32452554 DOI: 10.1002/jcp.29806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhao Z, Zhang C, Lin J, Zheng L, Li H, Qi X, Huo H, Lou X, Hammock BD, Hwang SH, Bao Y, Luo M. COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl 4 -Induced Liver Fibrosis and Portal Hypertension. Front Med (Lausanne) 2021;8:761517. [PMID: 35004731 DOI: 10.3389/fmed.2021.761517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sun CC, Zhang CY, Duan JX, Guan XX, Yang HH, Jiang HL, Hammock BD, Hwang SH, Zhou Y, Guan CX, Liu SK, Zhang J. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice. Biochem Biophys Res Commun 2020;523:1020-6. [PMID: 31973813 DOI: 10.1016/j.bbrc.2019.12.131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
11 Sun CP, Zhang XY, Morisseau C, Hwang SH, Zhang ZJ, Hammock BD, Ma XC. Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products. J Med Chem 2021;64:184-215. [PMID: 33369424 DOI: 10.1021/acs.jmedchem.0c01507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Li ZM, Xu SY, Feng YZ, Cheng YR, Xiong JB, Zhou Y, Guan CX. The role of NOX4 in pulmonary diseases. J Cell Physiol 2021;236:1628-37. [PMID: 32780450 DOI: 10.1002/jcp.30005] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Guan XX, Yang HH, Zhong WJ, Duan JX, Zhang CY, Jiang HL, Xiang Y, Zhou Y, Guan CX. Fn14 exacerbates acute lung injury by activating the NLRP3 inflammasome in mice. Mol Med 2022;28:85. [PMID: 35907805 DOI: 10.1186/s10020-022-00514-4] [Reference Citation Analysis]
14 Tiwari S, Yang J, Morisseau C, Durbin-Johnson B, Hammock BD, Gomes AV. Ibuprofen alters epoxide hydrolase activity and epoxy-oxylipin metabolites associated with different metabolic pathways in murine livers. Sci Rep 2021;11:7042. [PMID: 33782432 DOI: 10.1038/s41598-021-86284-1] [Reference Citation Analysis]
15 Guan XX, Rao DN, Liu YZ, Zhou Y, Yang HH. Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies. Int J Mol Sci 2021;22:10714. [PMID: 34639055 DOI: 10.3390/ijms221910714] [Reference Citation Analysis]
16 Kim HS, Moon SJ, Lee SE, Hwang GW, Yoo HJ, Song JW. The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis. Exp Mol Med 2021;53:864-74. [PMID: 33990688 DOI: 10.1038/s12276-021-00618-7] [Reference Citation Analysis]
17 Duan JX, Guan XX, Yang HH, Mei WX, Chen P, Tao JH, Li Q, Zhou Y. Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells. Int Immunopharmacol 2021;101:108211. [PMID: 34634687 DOI: 10.1016/j.intimp.2021.108211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tavares LA, Rezende AA, Santos JL, Estevam CS, Silva AMO, Schneider JK, Cunha JLS, Droppa-Almeida D, Correia-Neto IJ, Cardoso JC, Severino P, Souto EB, de Albuquerque-Júnior RLC. Cymbopogon winterianus Essential Oil Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model. Pharmaceutics 2021;13:679. [PMID: 34065064 DOI: 10.3390/pharmaceutics13050679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jankiewicz WK, Barnett SD, Stavniichuk A, Hwang SH, Hammock BD, Belayet JB, Khan AH, Imig JD. Dual sEH/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity. Front Pharmacol 2021;12:744776. [PMID: 34955823 DOI: 10.3389/fphar.2021.744776] [Reference Citation Analysis]
20 Zhang CY, Tan XH, Yang HH, Jin L, Hong JR, Zhou Y, Huang XT. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR. Int J Mol Sci 2022;23:8267. [PMID: 35897843 DOI: 10.3390/ijms23158267] [Reference Citation Analysis]
21 Wu Q, Zhang KJ, Jiang SM, Fu L, Shi Y, Tan RB, Cui J, Zhou Y. p53: A Key Protein That Regulates Pulmonary Fibrosis. Oxid Med Cell Longev 2020;2020:6635794. [PMID: 33312337 DOI: 10.1155/2020/6635794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]